380 related articles for article (PubMed ID: 34563872)
1. Purinergic signaling in the modulation of redox biology.
Savio LEB; Leite-Aguiar R; Alves VS; Coutinho-Silva R; Wyse ATS
Redox Biol; 2021 Nov; 47():102137. PubMed ID: 34563872
[TBL] [Abstract][Full Text] [Related]
2. ATP release, generation and hydrolysis in exocrine pancreatic duct cells.
Kowal JM; Yegutkin GG; Novak I
Purinergic Signal; 2015 Dec; 11(4):533-50. PubMed ID: 26431833
[TBL] [Abstract][Full Text] [Related]
3. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signaling: a potential therapeutic target for ischemic stroke.
Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of ecto-ATPase and ecto-ATPDase pathways to the biphasic effect of ATP on acetylcholine release from myenteric motoneurons.
Duarte-Araújo M; Nascimento C; Timóteo MA; Magalhães-Cardoso MT; Correia-de-Sá P
Br J Pharmacol; 2009 Feb; 156(3):519-33. PubMed ID: 19154428
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
8. The Role of Purinergic Signaling in Heart Transplantation.
Jiang Y; Lin J; Zheng H; Zhu P
Front Immunol; 2022; 13():826943. PubMed ID: 35529844
[TBL] [Abstract][Full Text] [Related]
9. Differential macrophage activation alters the expression profile of NTPDase and ecto-5'-nucleotidase.
Zanin RF; Braganhol E; Bergamin LS; Campesato LF; Filho AZ; Moreira JC; Morrone FB; Sévigny J; Schetinger MR; de Souza Wyse AT; Battastini AM
PLoS One; 2012; 7(2):e31205. PubMed ID: 22348056
[TBL] [Abstract][Full Text] [Related]
10. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
11. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases.
Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM
Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916
[TBL] [Abstract][Full Text] [Related]
12. Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Zeiner J; Loukovaara S; Losenkova K; Zuccarini M; Korhonen AM; Lehti K; Kauppinen A; Kaarniranta K; Müller CE; Jalkanen S; Yegutkin GG
J Mol Med (Berl); 2019 Mar; 97(3):341-354. PubMed ID: 30617853
[TBL] [Abstract][Full Text] [Related]
13. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
14. CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Kishore BK; Robson SC; Dwyer KM
Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180
[TBL] [Abstract][Full Text] [Related]
15. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
Matsuoka I; Ohkubo S
J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
[TBL] [Abstract][Full Text] [Related]
16. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.
Helenius M; Jalkanen S; Yegutkin G
Biochim Biophys Acta; 2012 Oct; 1823(10):1967-75. PubMed ID: 22967714
[TBL] [Abstract][Full Text] [Related]
18. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Yegutkin GG
Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
[TBL] [Abstract][Full Text] [Related]
20. P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
Claes P; Grobben B; Van Kolen K; Roymans D; Slegers H
Br J Pharmacol; 2001 Sep; 134(2):402-8. PubMed ID: 11564659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
